English
Français
Español
Deutsch
Italiano
Português
Nederlands
Polski
Română
Svenska
Dansk
Suomi
Čeština
Ελληνικά
Magyar
SlovenčinaData temporarily unavailable
Unable to load analysis for « - » for now. Try again in a few moments.
Investlytic score: 1/5 criteria met. Data as of 17/09/2026.
- ❌ Price trend failed
- ❌ Growth failed
- ❌ Debt failed
- ✅ P/E passed
- ❌ Correction failed
Price trend
Overall trend (8 years): insufficient progression (less than x1.5).
Price change 2018 → 2019: 26.33%
Price change 2019 → 2020: -1.27%
Price change 2020 → 2021: 32.46%
Price change 2021 → 2022: -32.27%
Price change 2022 → 2023: 22.79%
Price change 2023 → 2024: -28.59%
Price change 2024 → 2025: -29.10%
Price change 2025 → 2026: 15.44%
Price change 2026 (year to date): 15.00%
Financial growth
Revenue CAGR (8 years): 0.40%
Earnings CAGR (8 years): -29.21%
Growth status: weak or negative trend (<1%/yr) in revenue and earnings.
Debt
Debt-to-equity ratio: 0.89
Debt/equity > 0.5 (maximum threshold).
P/E (Price/Earnings)
P/E ratio: 22.76
P/E < 25.0 (maximum threshold).
Correction (6 months)
Current correction: 7.67% from the high over 6 months.
Insufficient correction (< 10.0%).
Criteria of the Investlytic model
- / 5Price trend
Price & trend
Interactive chart →💰 Dividend
Dividend ranking →⚖️ Comparison with the market
All stocks →| Stock | P/E | Dette/FP | Revenue growth | Rating |
|---|---|---|---|---|
| Arkema S.A. | 22.9 | 0.89 | +2.9 % | 🔒 |
| Vallourec S.A. | 9.1 | 0.40 | −1.1 % | – |
| Vicat S.A. | 9.0 | 0.57 | +4.4 % | – |
| Imerys S.A. | – | 0.86 | +0.1 % | – |
| Eramet S.a. | – | 3.52 | −1.7 % | – |
Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.
Detailed analysis · Price trend
-
Revenues & profits
Revenue and net income
Financial indicators
Annual financial statements
| Fiscal year | Revenue | Net income | Net margin | EPS | Revenue growth |
|---|